Galbraith Kenneth

Chair & CEO

DirectorOfficer

Latest Insider Transactions

10 transactions (past 365 days)

ZYME
CEO
Award
$0
216,000 shares @ $0.00
Filed 2026-01-12Trade 2026-01-12
Zymeworks Inc.
ZYME
CEO
Sale
-$689.8K
30,424 shares @ $22.67
Filed 2026-01-12Trade 2026-01-12
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
64,000 shares @ $0.00
Filed 2026-01-12Trade 2026-01-12
Zymeworks Inc.
ZYME
CEO
Sale
-$795.2K
31,686 shares @ $25.10
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
47,668 shares @ $0.00
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
66,666 shares @ $0.00
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Sale
-$568.6K
22,657 shares @ $25.10
Filed 2026-01-05Trade 2026-01-05
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
100,000 shares @ $0.00
Filed 2025-12-22Trade 2025-12-22
Zymeworks Inc.
ZYME
CEO
Sale
-$1.3M
47,528 shares @ $27.02
Filed 2025-12-22Trade 2025-12-22
Zymeworks Inc.
ZYME
CEO
Exercise Conversion
$0
100,000 shares @ $0.00
Filed 2025-12-22Trade 2025-12-22
Zymeworks Inc.